Early-phase Innate Immune Suppression in Murine Severe Sepsis Is Restored with Systemic Interferon-β

Background:Sepsis is a leading cause of death in the intensive care unit. Immune modulatory therapy targeting sepsis-associated proinflammatory responses has not shown survival benefit. Here, the authors evaluated innate immunity at the early stage of murine mild or severe peritoneal sepsis induced